Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
14.36 USD | -2.25% | -2.31% | -36.57% |
May. 06 | Barrington Cuts Price Target on Cross Country Healthcare to $21 From $24, Maintains Outperform Rating | MT |
May. 01 | (CCRN) CROSS COUNTRY HEALTHCARE Sees Q2 EPS Range $0.10 - $0.20 | MT |
Summary
- According to Refinitiv, the company's ESG score for its industry is good.
Strengths
- The company is one of the most undervalued, with an "enterprise value to sales" ratio at 0.31 for the 2024 fiscal year.
- The company appears to be poorly valued given its net asset value.
- Given the positive cash flows generated by its business, the company's valuation level is an asset.
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
- Historically, the company has been releasing figures that are above expectations.
Weaknesses
- According to Standard & Poor's' forecast, revenue growth prospects are expected to be very low for the next fiscal years.
- The company's currently anticipated earnings per share (EPS) growth for the next few years is a notable weakness.
- The company's profitability before interest, taxes, depreciation and amortization characterizes fragile margins.
- The company sustains low margins.
- For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
- The sales outlook for the group was lowered in the last twelve months. This change in forecast points out a decline in activity as well as pessimistic analyses of the company.
- For the past year, analysts have significantly revised downwards their profit estimates.
- For the last four months, earnings estimated by analysts have been revised downwards with respect to the next two years.
- Over the past four months, analysts' average price target has been revised downwards significantly.
- Over the past twelve months, analysts' opinions have been revised negatively.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Employment Services
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-36.57% | 511M | B+ | ||
-17.10% | 9.1B | A- | ||
-28.16% | 6.42B | A- | ||
-20.52% | 6.22B | B+ | ||
-11.45% | 3.41B | A- | ||
-7.68% | 3.27B | C+ | ||
+10.56% | 1.5B | - | ||
+2.51% | 1.5B | - | ||
-8.12% | 1.39B | - | ||
-10.79% | 1.13B | B- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- CCRN Stock
- Ratings Cross Country Healthcare, Inc.